What Are the 4 Stages of Ischaemic Heart Disease? Complete 2026 Doctor’s Guide

By Dr. Sagar Rajkuwar, ENT Specialist, Nashik, Maharashtra, India
🌐 www.entspecialistinnashik.com

Short answer: The 4 stages of ischaemic heart disease (IHD), also called coronary artery disease (CAD), are: Stage 1 — Subclinical atherosclerosis (silent plaque build-up); Stage 2 — Stable angina / chronic coronary syndrome; Stage 3 — Acute coronary syndrome (ACS) including unstable angina, NSTEMI and STEMI; and Stage 4 — Post-infarct complications, heart failure and end-stage ischaemic cardiomyopathy. Knowing exactly what are the 4 stages of ischaemic heart disease helps patients understand where they stand, what tests they need, and what treatment can slow, stop or reverse the disease. This 2026 ENT-authored guide, aligned with WHO, CDC, NHS, AHA/ACC 2023, and ESC 2024 Chronic Coronary Syndromes, walks you through every stage.

Table of Contents

1. Introduction
2. Why Staging Matters
3. Stage 1 — Subclinical Atherosclerosis
4. Stage 2 — Stable Angina / Chronic Coronary Syndrome
5. Stage 3 — Acute Coronary Syndrome (ACS)
6. Stage 4 — Heart Failure & Ischaemic Cardiomyopathy
7. Alternative Staging Systems
8. How Stages Progress
9. Diagnosis at Each Stage
10. Treatment by Stage
11. Prognosis & Reversibility
12. External Video Resource
13. FAQs
14. Conclusion
15. References

1. Introduction

Ischaemic heart disease is a progressive condition — rarely does the first symptom come without years of silent plaque formation. The question what are the 4 stages of ischaemic heart disease is therefore the first thing many newly diagnosed patients ask. Clinicians use staging to decide how aggressively to intervene, which investigations to order, and what long-term prognosis to expect.

2. Why Staging Matters

• Targets screening intensity
• Guides lifestyle vs medical vs interventional therapy
• Explains individual risk
• Allows patients to track their own progress
• Shapes cost-effective healthcare delivery

So what are the 4 stages of ischaemic heart disease? Let’s walk through each in detail.

3. Stage 1 — Subclinical Atherosclerosis

3.1 What it is

Silent plaque build-up in the coronary arteries without symptoms. Begins as early as the 2nd–3rd decade of life, especially in South Asians.

3.2 Underlying biology

• Endothelial dysfunction
• LDL infiltration and oxidation
• Foam cell formation
• Early fatty streaks, growing into fibrous plaques

3.3 How it is detected

• Coronary artery calcium (CAC) score
• Carotid intima–media thickness (CIMT)
• Risk-factor assessment: BP, lipids, HbA1c, Lp(a), hs-CRP
• ASCVD risk score, QRISK3, SCORE2

3.4 Management

Aggressive risk-factor control: Mediterranean/DASH diet, 150+ minutes/week exercise, smoking cessation, BP <130/80, LDL target depending on risk category, treat diabetes to HbA1c <7%. Low-dose statins may be started if CAC ≥100 or borderline risk. This is the stage where what are the 4 stages of ischaemic heart disease is most reversible.

4. Stage 2 — Stable Angina / Chronic Coronary Syndrome

4.1 Clinical picture

Predictable, exertional chest discomfort relieved by rest or nitrates. ESC 2024 now groups this under Chronic Coronary Syndromes (CCS).

4.2 Classic features

• Central/retrosternal pressure or tightness
• Triggered by physical exertion, cold, emotion, or heavy meals
• Relieved in 1–5 minutes by rest or sublingual nitroglycerin
• CCS Grade I–IV based on severity (Canadian Cardiovascular Society scale)

4.3 Pathology

Fibrous plaque causing >50–70% stenosis in a coronary artery. Supply fails only during increased demand.

4.4 Investigations

• Resting ECG
• Treadmill (stress) ECG, stress echocardiography, MPI (SPECT), cardiac MRI
• CT coronary angiography — first-line in most 2024 ESC pathways
• Invasive coronary angiography if high pre-test probability

4.5 Treatment

• Lifestyle optimisation
• Anti-anginals: beta-blockers, calcium-channel blockers, long-acting nitrates, ranolazine, trimetazidine, ivabradine
• Antiplatelet (aspirin), high-intensity statin, ACE inhibitor if indicated
• Revascularisation: PCI or CABG for refractory symptoms or high-risk anatomy (left main, 3-vessel disease, diabetes)

5. Stage 3 — Acute Coronary Syndrome (ACS)

5.1 Spectrum of ACS

• Unstable angina — new, resting, or crescendo angina without troponin rise
• NSTEMI — non-ST-elevation myocardial infarction
• STEMI — full-thickness myocardial infarction with ST-elevation

5.2 Mechanism

Rupture or erosion of a vulnerable plaque triggers thrombus formation, causing partial or complete coronary occlusion.

5.3 Symptoms

• Severe, prolonged chest pain >20 minutes
• Pain radiating to arm, jaw, back, epigastrium
• Severe sweating, nausea
• Breathlessness, palpitations, syncope
• Sense of impending doom

5.4 Diagnosis

• Serial 12-lead ECG
• High-sensitivity troponin
• Bedside echocardiography
• Immediate coronary angiography for STEMI or high-risk NSTEMI

5.5 Treatment

• MONA-B (Morphine, Oxygen if hypoxic, Nitrates, Aspirin, Beta-blocker)
• Dual antiplatelet therapy — aspirin + ticagrelor or prasugrel
• Anticoagulation — heparin or bivalirudin
• High-intensity statin
• Primary PCI within 90 minutes (gold standard), or fibrinolysis
• Early CABG in selected multivessel disease

Stage 3 is where delay costs lives — “time is muscle”. This stage dramatically illustrates why knowing what are the 4 stages of ischaemic heart disease matters so much.

6. Stage 4 — Heart Failure & Ischaemic Cardiomyopathy

6.1 Clinical picture

After large or recurrent infarcts, the left ventricle dilates and loses function → ischaemic cardiomyopathy with heart failure with reduced ejection fraction (HFrEF), arrhythmias, and sometimes sudden death.

6.2 Symptoms

• Exertional breathlessness, orthopnoea, paroxysmal nocturnal dyspnoea
• Pedal oedema, raised JVP, hepatomegaly
• Fatigue, reduced effort tolerance
• Arrhythmias — atrial fibrillation, ventricular tachycardia
• Recurrent chest pain or anginal equivalents
• Episodes of acute decompensation

6.3 Complications

• Left-ventricular aneurysm & mural thrombus
• Functional mitral regurgitation
• Pulmonary hypertension
• Cardio-renal syndrome
• Sudden cardiac death

6.4 Management

• Guideline-directed medical therapy (“four pillars“): ACE-I/ARB/ARNI, beta-blocker, mineralocorticoid antagonist, SGLT2 inhibitor
• Diuretics for congestion
• Cardiac resynchronisation therapy (CRT) & implantable cardioverter-defibrillator (ICD)
• Revascularisation if viable myocardium
• Advanced therapies: LVAD, heart transplantation

7. Alternative Staging Systems

• SCAI SHOCK classification — stages A–E for cardiogenic shock after MI
• CCS (Canadian Cardiovascular Society) angina classification — I–IV
• NYHA functional class — I–IV for heart failure
• Pathological grading — fatty streak → fibrous plaque → complicated plaque
• Imaging stages — CAC score, SYNTAX score, Gensini score

Still, the simplest clinical teaching uses the 4-stage model this article follows: what are the 4 stages of ischaemic heart disease in day-to-day practice is Stages 1 → 4 as above.

8. How Stages Progress

Progression is not linear or inevitable. Many patients stay in Stage 1 for decades. Others jump directly from Stage 1 (silent plaque) to Stage 3 (sudden plaque rupture → MI) without ever experiencing stable angina — this is why primary prevention matters more than symptom-chasing.

9. Diagnosis at Each Stage

• Stage 1: CAC, lipids, risk calculators
• Stage 2: Stress test, CT coronary angiography, invasive angiography
• Stage 3: ECG, troponin, invasive angiography
• Stage 4: Echocardiography (ejection fraction), BNP/NT-proBNP, cardiac MRI, viability imaging

10. Treatment by Stage

• Stage 1: Lifestyle, selective statins
• Stage 2: Anti-anginals + statin + aspirin ± revascularisation
• Stage 3: PCI/thrombolysis, dual antiplatelet, high-intensity statin, beta-blocker, ACE-I
• Stage 4: HF pillars, device therapy, transplant evaluation

11. Prognosis & Reversibility

Stage 1 is largely reversible with aggressive risk-factor control. Stage 2 can be stabilised and symptoms abolished. Stage 3 outcomes depend on time to reperfusion. Stage 4 is managed to slow progression — some patients recover ventricular function after revascularisation of hibernating myocardium.

12. External Video Resource

Watch a 10-minute visual explainer on what are the 4 stages of ischaemic heart disease:

YouTube: Stages of Ischaemic Heart Disease – British Heart Foundation / Osmosis

13. FAQs

Q1. Can you skip stages?

Yes. Sudden plaque rupture can take a patient from Stage 1 straight to Stage 3 (acute MI).

Q2. Is Stage 4 end-of-life?

Not necessarily. Modern HF therapy and device/transplant options give many Stage 4 patients years of good quality life.

Q3. Can diet alone reverse Stage 1?

In many patients, a Mediterranean/DASH diet, exercise, weight loss, and smoking cessation can stabilise or partially regress early plaque.

Q4. What’s the role of CT coronary angiography?

It is now the first-line test in Stage 2 symptomatic patients per ESC 2024.

Q5. How often should screening be done?

Lipids every 1–2 years from age 20; ASCVD risk every 4–6 years from age 40; CAC in intermediate-risk adults.

Q6. Can arrhythmia be the only sign of IHD?

Yes, especially in Stage 4 ischaemic cardiomyopathy or silent ischaemia in diabetics.

Q7. Are young adults safe from IHD?

Not entirely. Familial hypercholesterolaemia, cocaine use, SCAD, and connective-tissue disorders can cause IHD below age 40.

Q8. How can I know my current stage?

A detailed clinical assessment plus ECG, lipids, HbA1c, and sometimes CAC or stress test will place you accurately on the IHD staging ladder.

14. Conclusion

So, what are the 4 stages of ischaemic heart disease? Stage 1 is silent atherosclerosis, Stage 2 is stable angina / chronic coronary syndrome, Stage 3 is acute coronary syndrome, and Stage 4 is ischaemic cardiomyopathy and heart failure. The further you move along this ladder, the harder it is to reverse — but at every stage, evidence-based lifestyle and medical therapy can slow or stop the disease. Early detection with CAC and lipid screening, combined with Mediterranean/DASH diet, exercise, smoking cessation, and timely medications, gives you the greatest chance of staying in Stage 1 for life.

15. References

1. Vrints C, et al. 2024 ESC Guidelines on Chronic Coronary Syndromes.
2. Byrne RA, et al. 2023 ESC Guidelines on Acute Coronary Syndromes.
3. WHO Cardiovascular Diseases Fact Sheet, 2024.
4. CDC. Heart Disease Facts, 2024.
5. NHS UK. Coronary Heart Disease, 2024.
6. Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
7. Grundy SM, et al. 2018 AHA/ACC Cholesterol Guideline (updated 2023).

📞 ENT Consultation & Surgery

Dr. Sagar Rajkuwar (MS-ENT)
Prabha ENT Clinic, Ambad, Nashik
📱 7387590194 | 9892596635
🌐 www.entspecialistinnashik.com

Medical Disclaimer

Medical Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Audiogram results should be interpreted by a qualified audiologist or ENT specialist. If you have sudden hearing loss, severe dizziness, ear discharge, or other concerning symptoms, seek medical evaluation promptly. For cardiac assessment, always consult a qualified cardiologist.